| Previous close | 1.8800 |
| Open | 2.0600 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 133.00 |
| Expiry date | 2024-05-31 |
| Day's range | 1.5000 - 2.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Yahoo Finance Video
Nvidia, advances in cancer research, climate change under Trump: Market Domination
Nvidia (NVDA) continues to dominate the tech sector as the company's shares move past $1,100. The chip giant earned a boost from Elon Musk, who announced that xAI's supercomputer will run on Nvidia technology. Meanwhile, Tesla (TSLA) shareholders are awaiting an important vote on June 13, which will dictate the fate of Musk's proposed pay package of $56 billion. The American Society of Clinical Oncology (ASCO) will hold its annual meeting in Chicago this week, exploring the latest advancements in the cancer research sector. Tom Steyer, Galvanize Climate Solutions Co-Executive Chair, also joins the show to give insight into the state of climate change mitigation under a possible second Trump presidency. For more expert insight and the latest market action, click here.
Investor's Business DailyDow Jones Tech Giant Apple, AI Leader CrowdStrike Eye Buy Points
Dow Jones tech giant Apple stock and AI Leader CrowdStrike are approaching new buy points in today's stock market.
ZacksIs Trending Stock Novo Nordisk A/S (NVO) a Buy Now?
Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
